Exos TFP Holdings’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Exos TFP Holdings’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,000	Closed	-$650K	–	233
2023 Q3	$650K	Hold	60,000	–	–	0.35%	73
2023 Q2	$639K	Sell	60,000 -2,500	-4%	-$26.3K	0.32%	79
2023 Q1	$653K	Hold	62,500	–	–	0.16%	168
2022 Q4	$639K	Buy	+62,500	New	+$634K	0.18%	138

Exos TFP Holdings's BIOS Position: Q4 2023 in Review

Exos TFP Holdings sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 60,000 shares — an estimated $650K sold.

Exos TFP Holdings first reported a position in BIOS in Q4 2022 and held it in 4 quarters. The position peaked at $653K in Q1 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Exos TFP Holdings reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Exos TFP Holdings sold 60,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $650K.
Exos TFP Holdings first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 4 quarters.
Exos TFP Holdings's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $653K in Q1 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Exos TFP Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.